ARTV
Price:
$3.775
Market Cap:
$92.66M
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (...[Read more]
Industry
Biotechnology
IPO Date
2024-07-19
Stock Exchange
NASDAQ
Ticker
ARTV
According to Artiva Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -45.64%. This represents a change of 281.22% compared to the average of -11.97% of the last 4 quarters.
The mean historical ROE of Artiva Biotherapeutics, Inc. over the last ten years is 31.92%. The current -45.64% ROE has changed -243.00% with respect to the historical average. Over the past ten years (40 quarters), ARTV's ROE was at its highest in in the March 2024 quarter at 7.99%. The ROE was at its lowest in in the September 2025 quarter at -16.66%.
Average
31.92%
Median
29.30%
Minimum
-31.34%
Maximum
83.42%
Discovering the peaks and valleys of Artiva Biotherapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 83.42%
Minimum Annual Increase = -283.33%
Minimum Annual ROE = -31.34%
| Year | ROE | Change |
|---|---|---|
| 2024 | -31.34% | -283.33% |
| 2023 | 17.09% | -58.81% |
| 2022 | 41.50% | -48.66% |
| 2021 | 80.83% | -3.10% |
| 2020 | 83.42% | Infinity% |
The current ROE of Artiva Biotherapeutics, Inc. (ARTV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.08%
5-year avg
38.30%
10-year avg
31.92%
Artiva Biotherapeutics, Inc.’s ROE is greater than Precision BioSciences, Inc. (-213.79%), greater than Adverum Biotechnologies, Inc. (-3844.85%), less than Sutro Biopharma, Inc. (861.99%), greater than Fractyl Health, Inc. Common Stock (-3645.22%), greater than ALX Oncology Holdings Inc. (-115.67%), greater than InflaRx N.V. (-71.27%), greater than Zentalis Pharmaceuticals, Inc. (-51.62%), greater than Metagenomi, Inc. Common Stock (-38.76%), greater than Connect Biopharma Holdings Limited (-44.18%), greater than Shattuck Labs, Inc. (-73.82%),
| Company | ROE | Market cap |
|---|---|---|
| -213.79% | $66.54M | |
| -3844.85% | $92.06M | |
| 861.99% | $79.86M | |
| -3645.22% | $142.94M | |
| -115.67% | $74.28M | |
| -71.27% | $74.52M | |
| -51.62% | $101.15M | |
| -38.76% | $67.21M | |
| -44.18% | $141.98M | |
| -73.82% | $142.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artiva Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Artiva Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Artiva Biotherapeutics, Inc.'s ROE?
How is the ROE calculated for Artiva Biotherapeutics, Inc. (ARTV)?
What is the highest ROE for Artiva Biotherapeutics, Inc. (ARTV)?
What is the 3-year average ROE for Artiva Biotherapeutics, Inc. (ARTV)?
What is the 5-year average ROE for Artiva Biotherapeutics, Inc. (ARTV)?
How does the current ROE for Artiva Biotherapeutics, Inc. (ARTV) compare to its historical average?